The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

计划入组 30 人 · 首次发布于 2026 年 5 月 1 日

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

计划入组 210 人 · 首次发布于 2016 年 6 月 15 日

Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).

计划入组 17 人 · 首次发布于 2021 年 11 月 22 日

FP-045

Pulmonary Hypertension(Vascugen)

NOTCH inhibitors (pulmonary hypertension)

Kidney & Hypertension Center

United States

PULMONARY HOMECARE

United States

Shanghai Institute of Hypertension

China

Pulmovant Completes Enrollment in Phase 2 Trial of Mosliciguat for Pulmonary Hypertension Associated with Interstitial Lung Disease

Liquidia's Yutrepia Receives Tentative FDA Approval for Pulmonary Hypertension

Roivant Sciences Gains Orphan Drug Designation in Japan for Mosliciguat in Pulmonary Hypertension